For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
The FDA granted priority review, with a decision expected by June 19, 2025. LEN represents a novel class of HIV therapies by targeting the viral capsid, a multifunctional protein essential for HIV ...
New findings reveal the presence of replication-competent Oropouche virus in semen, posing fresh questions about sexual transmission risks and public health safety. Research Letter: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback